BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 16504675)

  • 21. Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report.
    Nowacka-Cieciura E; Perkowska-Ptasińska A; Sulikowska-Rowińska A; Cieciura T; Wazna E; Durlik M
    Transplant Proc; 2009; 41(1):441-5. PubMed ID: 19249576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO
    Transplant Proc; 2009; 41(6):2659-63. PubMed ID: 19715995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy.
    Ji SM; Li LS; Sha GZ; Chen JS; Liu ZH
    Transplant Proc; 2007 Jun; 39(5):1402-5. PubMed ID: 17580148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteinuria in transplant patients associated with sirolimus.
    Franco AF; Martini D; Abensur H; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):449-52. PubMed ID: 17362756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirolimus experience in heart transplantation.
    Aranda-Dios A; Lage E; Sobrino JM; Mogollón MV; Guisado A; Cabezón S; Hinojosa R; Hernández A; Ordóñez A
    Transplant Proc; 2006 Oct; 38(8):2547-9. PubMed ID: 17097997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus as an alternative to anticalcineurin therapy in heart transplantation: experience of a single center.
    Fernandez-Valls M; Gonzalez-Vilchez F; de Prada JA; Ruano J; Ruisanchez C; Martin-Duran R
    Transplant Proc; 2005 Nov; 37(9):4021-3. PubMed ID: 16386615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion to everolimus in kidney transplant recipients with decreased renal function.
    Inza A; Balda S; Alvarez E; Zárraga S; Gaínza FJ; Lampreabe I
    Transplant Proc; 2009; 41(6):2134-6. PubMed ID: 19715854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirolimus improves renal function in cardiac transplantation.
    Cabezón S; Lage E; Hinojosa R; Ordóñez A; Campos A
    Transplant Proc; 2005 Apr; 37(3):1546-7. PubMed ID: 15866668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the efficacy and safety of conversion to sirolimus in 85 renal transplant recipients.
    Sola E; Lopez V; Gutierrez C; Cabello M; Burgos D; Gonzalez Molina M; Hernandez D
    Transplant Proc; 2009; 41(6):2137-8. PubMed ID: 19715855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of low-dose cyclosporine therapy before transplantation in kidney allograft recipients.
    Khosroshahi HT; Badrogli N; Jahannavard N; Oskuii R; Bahluli A; Azar SA; Ardalan M
    Transplant Proc; 2009 Sep; 41(7):2757-60. PubMed ID: 19765427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic effect of sirolimus against chronic allograft nephropathy in kidney transplant recipients].
    Wang CX; Chen SY; Chen LZ; Liu LS; Fei JG; Deng SX; Qiu J; Li J; Zheng KL; Wu PG; Ji YL; Zhu LY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1924-6. PubMed ID: 18159022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of renal function after heart transplantation: initial single-center experience with sirolimus.
    De Meester JM; Van Vlem B; Walravens M; Vanderheyden M; Verstreken S; Goethals M; Kerre N; Wellens F
    Transplant Proc; 2005 May; 37(4):1835-8. PubMed ID: 15919481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
    Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery of renal function in heart transplantation patients after conversion from a calcineurin inhibitor-based therapy to sirolimus.
    Ayub-Ferreira SM; Avila MS; Feitosa FS; Souza GE; Mangini S; Marcondes-Braga FG; Issa VS; Bacal F; Chizzola PR; Cruz FD; Bocchi EA
    Transplant Proc; 2010 Mar; 42(2):542-4. PubMed ID: 20304188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria.
    Saurina A; Campistol JM; Piera C; Diekmann F; Campos B; Campos N; de las Cuevas X; Oppenheimer F
    Nephrol Dial Transplant; 2006 Feb; 21(2):488-93. PubMed ID: 16280369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of variability of sirolimus trough level on chronic allograft nephropathy.
    Wu MJ; Shu KH; Lian JD; Yang CR; Cheng CH; Chen CH
    Transplant Proc; 2008 Sep; 40(7):2202-5. PubMed ID: 18790192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients.
    Stallone G; Di Paolo S; Schena A; Infante B; Grandaliano G; Battaglia M; Gesualdo L; Schena FP
    Transplantation; 2003 Apr; 75(7):998-1003. PubMed ID: 12698087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirolimus in chronic allograft nephropathy.
    Wu MJ; Shu KH; Cheng CH; Chen CH
    Transplant Proc; 2004 Sep; 36(7):2053-5. PubMed ID: 15518743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.